CompanyHealthHardware
Plexium
Plexium is a San Diego precision medicine company designing small-molecule protein degraders - monovalent direct degraders and molecular glues - that switch off disease-driving proteins traditionally considered undruggable. Its DELTA Discovery platform runs ultra-high-throughput cell-based screening to find and optimize new degrader chemistry across cancer and neurological disease.
2017Founded
San DiegoHQ
$60.1MVenture (round not specified)
biotechtargeted-protein-degradationtpdmolecular-gluesmonovalent-degradersdrug-discovery